AEHR
Aehr Test Systems
NASDAQ · Technology · Semiconductors · US
$84.57
+10.88%Year over year
Reported trailing growth
- Revenue
- -13.7%
- EBITDA
- —
- EBIT
- —
- EPS
- -75.8%
- Free cash flow
- +56.6%
- Operating cash flow
- +55.3%
Forward estimates
Based on analyst estimates
- Revenue
- +188.7%
- EBITDA
- +345.4%
- EPS
- +459.1%
Three-year CAGR
- Revenue
- -8.4%
- EBITDA
- —
- EBIT
- —
- Net income
- -82.3%
- EPS
- -76.9%
- Free cash flow
- +56.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of May 1, 2026